Paradigm Biocapital Advisors LP 13D and 13G filings for Edgewise Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-03 4:36 pm Purchase | 2025-01-27 | 13G | Edgewise Therapeutics, Inc. EWTX | Paradigm Biocapital Advisors LP | 4,738,929 5.000% | 4,738,929 (New Position) | Filing |